With a decision Tuesday, the 3rd US Circuit Court of Appeals has brought to a screeching if hopefully temporary halt for efforts to establish a groundbreaking permitted safer injection facility in the city of Philadelphia. In the case of US v. Safehouse, the nonprofit group set to run the site, the court held that allowing the supervised onsite consumption of illegal drugs will break the law because it conflicts with a 35-year-old amendment to the Controlled Substances Act aimed at crack houses.
The Vancouver safer injection site. We still can t have those in America. Yet. (vcha.ca)Never mind that the city is in the midst of an opioid overdose epidemic and needs to try something new after decades of failed prohibitionist drug policies. The sanctity of the drugs laws must be maintained, the court held: Though the opioid crisis may call for innovative solutions, local innovations may not break federal law, it opined.
December 16, 2020
A new study shows that implementing PrEP distribution within a community-based syringe services program gets the medication into the hands of women who inject drugs a population disproportionately impacted by HIV.
When taken daily, pre-exposure prophylaxis, or PrEP, is a highly effectiveway to prevent HIV transmission, according to the Centers for Disease Control and Prevention. Now a new study shows that implementing PrEP distribution within a community-based syringe services program gets the medication into the hands of women who inject drugs a population disproportionately impacted by HIV. The results, from researchers at Drexel University’s Dornsife School of Public Health, Dornsife School of Public Health, were recently published in the
E-Mail
When taken daily, pre-exposure prophylaxis, or PrEP, is a highly effective way to prevent HIV transmission, according to the Centers for Disease Control and Prevention. Now a new study shows that implementing PrEP distribution within a community-based syringe services program gets the medication into the hands of women who inject drugs a population disproportionately impacted by HIV. The results, from researchers at Drexel University s Dornsife School of Public Health, Dornsife School of Public Health, were recently published in the
Journal of Acquired Immune Deficiency Syndrome. In the first demonstration project among women who inject drugs, known as Project Sexual Health Equity (Project SHE), the team prescribed up to 24 weeks of daily PrEP, to 95 adult cisgender women those whose gender identity matches their sex assigned at birth. The study was based at the largest syringe services program in the mid-Atlantic Prevention Point Philadelphia located in the K